Why Obeda May Not Work for You: 7 Honest Reasons

Obeda is Dr. Reddy's semaglutide injection, launched in India in March 2026 for adults with type 2 diabetes. Semaglutide has strong clinical evidence behind it, and it often helps with weight as well as blood sugar. But it does not work equally well for everyone. If you have started treatment and the results are disappointing -- or if you want to understand the risks before you begin -- this guide covers the most common reasons why semaglutide underperforms.

Most of these reasons are fixable. A few are not. Knowing the difference helps.

Important: Always consult your healthcare provider before starting any medication. This article is for informational purposes only.

Reason 1: You Are Still on the Starter Dose

The most common mistake people make is judging Obeda by its 0.25mg starter dose results.

The 0.25mg dose is not a therapeutic dose. It is a tolerance-building dose -- designed to help your body adjust to semaglutide without overwhelming side effects. Appetite suppression at this dose is mild. Weight loss in the first four weeks is typically minimal.

Significant results come at 0.5mg and 1mg. If you are two weeks in and not losing weight, you are not failing -- you are still in the adjustment phase.

What to do: Be patient. Follow the prescribed escalation schedule. Do not judge the medication until you have been at 0.5mg or 1mg for at least 8 weeks.

Reason 2: Your Diet Has Not Changed

Obeda dramatically reduces appetite. But it does not change what you eat when you do eat.

Many patients find they are eating smaller portions -- but those smaller portions are still predominantly refined carbohydrates, fried foods, and high-calorie snacks. Obeda cannot overcome poor food quality.

The evidence is clear: patients who combine semaglutide with a protein-rich, whole-food diet consistently outperform those who do not change their eating patterns. The medication reduces appetite; your food choices determine how much fat you actually lose.

What to do: Read what to eat while taking Obeda. Prioritise protein at every meal (dal, eggs, paneer, chicken, fish). Reduce refined carbohydrates and ultra-processed snacks. You do not need to starve -- just eat better.

Reason 3: You Are Not Taking It Consistently

Semaglutide's appetite suppression is cumulative. It builds over weeks. Missing weekly injections disrupts that steady-state effect and can set your progress back.

Inconsistent use is common when people have side effects early on, travel, or run low on stock. If you miss a dose, follow the missed-dose instructions in your pack leaflet (for semaglutide, a missed dose is usually taken within 5 days, otherwise skipped). If you have missed two or more weeks, ask your doctor how to restart, because restarting at your full dose can bring back strong side effects.

What to do: Set a recurring weekly alarm. Keep at least one pen in reserve. If nausea or other side effects are causing you to delay or skip injections, speak to your doctor about managing them rather than stopping the medication.

Reason 4: An Underlying Condition Is Working Against You

Several medical conditions make weight loss on semaglutide significantly harder:

• Hypothyroidism (underactive thyroid): A common condition in Indian women that slows metabolism. If untreated or undertreated, it can make weight loss on Obeda noticeably harder.
• PCOS (polycystic ovary syndrome): Insulin resistance associated with PCOS makes fat loss harder, particularly around the abdomen.
• Sleep apnoea: Disrupted sleep raises cortisol and ghrelin (hunger hormone), counteracting semaglutide's appetite effect.
• Insulin resistance: Beyond what Obeda addresses, severe insulin resistance may require additional treatment.

What to do: Ask your doctor whether your thyroid levels and other relevant markers should be checked before assuming Obeda is not working. Treating an underlying condition can unlock the weight loss that the medication alone was not achieving.

Reason 5: Chronic Stress and Poor Sleep

These are consistently underestimated by patients and sometimes by doctors too.

Chronic stress is linked with higher cortisol, abdominal fat storage and stress eating, which can blunt semaglutide's appetite-suppressing effects. People under significant work, financial, or personal stress often see blunted results even on adequate doses.

Sleep deprivation raises ghrelin (hunger hormone) and lowers leptin (fullness hormone), directly counteracting what Obeda is trying to do. Poor sleep can make you feel hungrier than you should, even on the medication.

What to do: Sleep quality and stress management are not optional additions to your treatment plan -- they are core components. Aim for 7-8 hours of sleep. Identify and reduce major stressors. This is easier said than done, but it makes a measurable difference to outcomes.

Reason 6: Your Dose Is Too Low for Your Response Profile

Not everyone responds equally at the same dose. Some patients need 1mg to see meaningful results; others respond well at 0.5mg. Obeda pens come in 2mg and 4mg strengths, each giving at least 4 weekly doses, which matches the usual 0.25mg to 1mg weekly diabetes doses. As of October 2026, Dr. Reddy's has not announced an Obeda pen for the 2mg weekly dose used in some other countries; check your pack leaflet for the doses your pen delivers.

If you have been at 0.5mg for 8 weeks and results have stalled, and you are tolerating the medication well, your doctor may consider titrating up to 1mg.

This is a clinical decision -- do not self-escalate without your doctor's guidance. But do not stay on an insufficient dose indefinitely if the medication is working in other ways (appetite reduction is present, but weight loss has plateaued).

What to do: Track your appetite changes and weight weekly. If appetite suppression is present but weight loss has stalled after 8 weeks, bring this data to your doctor for a dose review.

Reason 7: You Stopped Too Early

Semaglutide is a long-term treatment. The STEP 1 trial, which showed 14.9% average weight loss, ran for 68 weeks -- over 16 months -- and used semaglutide 2.4mg (the Wegovy dose) in adults without diabetes. Obeda's diabetes doses are lower, and weight loss with them is usually smaller. Many patients stop at 8-12 weeks when results feel slow, just before the medication reaches its full effect.

Early stopping is one of the biggest predictors of disappointing results on semaglutide. The medication builds its effect over time; abandoning it at month 2-3 means leaving most of the results on the table.

What to do: Agree with your doctor when to review whether the medication is working; this is often several months after reaching your maintenance dose. Read the Obeda results timeline to understand what the realistic pace of progress looks like.

What to Do If None of These Apply

If you have addressed all seven of these factors and are still seeing minimal response after 16 weeks at 1mg, discuss true non-response with your doctor. Options include:

• Blood tests to rule out remaining underlying conditions
• Whether a higher weekly dose of semaglutide is appropriate and available for you
• Assessment for other contributing factors
• Discussion about alternative or additional treatments (such as tirzepatide)

True non-response to semaglutide is uncommon but real. It is not a failure -- it is information, and it opens the door to exploring better-suited options.

How Weight Easy Addresses These Root Causes

Most of the reasons Obeda underperforms are modifiable -- diet, consistency, side effect management, stress, sleep. Weight Easy's platform is designed to address precisely these factors systematically.

Personalised dietary guidance, weekly habit coaching, side effect tracking, and progress monitoring -- all structured to maximise your response to Obeda rather than leave results to chance.

If you are starting Obeda, the right support can make a significant difference. Weight Easy helps you stay consistent, manage side effects, and achieve better results.

The Bottom Line

Obeda helps many patients who use it correctly, consistently, and with appropriate dietary support. When it does not work as expected, one or more of these seven reasons is often present and addressable.

Do not give up before giving it a proper trial. Do not expect it to work without your participation. And if genuine non-response occurs, speak to your doctor about what comes next.

Get urgent medical help if you develop severe abdominal pain that will not go away (it may spread to your back), repeated vomiting with signs of dehydration, or swelling of the face or throat. If you take insulin or a sulfonylurea, watch for signs of low blood sugar such as shakiness, sweating and confusion.

Consult your healthcare provider before starting any medication.

Sources

• Indian Pharma Post — Dr. Reddy's launches Obeda (semaglutide) for type 2 diabetes, 2 mg and 4 mg pens: https://www.indianpharmapost.com/news/lite/dr-reddys-laboratories-launches-indias-first-dcgi-approved-semaglutide-injection-obeda-for-type-2-diabetes-19429
• Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1) — PubMed: https://pubmed.ncbi.nlm.nih.gov/33567185/
• Central Drugs Standard Control Organisation (CDSCO): https://cdsco.gov.in/opencms/opencms/en/Home/
• MedicalDialogues — India semaglutide market and brand launch context: https://medicaldialogues.in/news/industry/pharma/indias-semaglutide-market-set-for-generic-boom-as-patents-expire-over-50-brands-lined-up-for-launch-see-full-list-165838
• Ozempic prescribing information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209637s025lbl.pdf
• WHO — obesity and overweight: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight